Medicare Enrolled

Dr. Janna Prater, M.D.

Endocrinology · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
9880 BUSTLETON AVE, Philadelphia, PA 19115
2158271500
In practice since 2010 (15 years)
NPI: 1003129685 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Prater from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Prater? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Prater

Dr. Janna Prater is an endocrinology specialist in Philadelphia, PA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Prater performed 1,096 Medicare services across 604 unique beneficiaries.

Between the years covered by Open Payments, Dr. Prater received a total of $21,224 from 61 pharmaceutical and/or device companies across 817 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Prater is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 29% volume in PA $21,224 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,096
Medicare services
Top 29% in PA for endocrinology
604
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~73 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
543 $93 $244
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
279 $66 $134
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
81 $11 $65
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
71 $26 $104
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
71 $104 $276
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
51 $110 $366
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$21,224
Total received (2018-2024)
Avg $3,032/year across 7 years
Top 15% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
817
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,134 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,681
2023
$3,558
2022
$3,293
2021
$3,702
2020
$2,454
2019
$2,296
2018
$3,241

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Corcept Therapeutics
$363
Novo Nordisk Inc
$278
Boehringer Ingelheim Pharmaceuticals, Inc.
$240
Amgen Inc.
$217
AIMMUNE THERAPEUTICS, INC.
$187
Radius Health, Inc.
$162
Novartis Pharmaceuticals Corporation
$157
Xeris Pharmaceuticals, Inc.
$146
ABBVIE INC.
$99
Bayer Healthcare Pharmaceuticals Inc.
$85
SANOFI-AVENTIS U.S. LLC
$72
Lilly USA, LLC
$70
Dexcom, Inc.
$59
Antares Pharma, Inc.
$57
Amphastar Pharmaceuticals, Inc.
$54
Abbott Laboratories
$47
Chiesi USA, Inc.
$45
Medtronic, Inc.
$37
Mannkind Corporation
$37
Esperion Therapeutics, Inc.
$34
Astellas Pharma US Inc
$33
Ascensia Diabetes Care Us Inc.
$32
Tandem Diabetes Care, Inc.
$24
BETA BIONICS, INC.
$20
Insulet Corporation
$20
Vifor Pharma, Inc.
$19
Verity Pharmaceuticals Inc.
$19
Kyowa Kirin, Inc.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
SANOFI US SERVICES INC.
$16
Tolmar, Inc.
$15
Top 3 companies account for 32.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$4,718
AstraZeneca Pharmaceuticals LP
$3,152
SANOFI-AVENTIS U.S. LLC
$2,228
Lilly USA, LLC
$1,292
Amgen Inc.
$969
Corcept Therapeutics
$863
Xeris Pharmaceuticals, Inc.
$650
Boehringer Ingelheim Pharmaceuticals, Inc.
$621
Radius Health, Inc.
$501
Janssen Pharmaceuticals, Inc
$473
Medtronic, Inc.
$431
Novartis Pharmaceuticals Corporation
$430
Mannkind Corporation
$360
Amarin Pharma Inc.
$341
MannKind Corporation
$317
Bayer Healthcare Pharmaceuticals Inc.
$276
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$259
Intuity Medical Inc
$227
Antares Pharma, Inc.
$218
Bayer HealthCare Pharmaceuticals Inc.
$193
AIMMUNE THERAPEUTICS, INC.
$187
Medtronic MiniMed, Inc.
$173
Becton, Dickinson and Company
$165
Dexcom, Inc.
$160
Merck Sharp & Dohme Corporation
$139
AbbVie Inc.
$134
NESTLE HEALTHCARE NUTRITION INC.
$125
AbbVie, Inc.
$125
Embecta Corp.
$121
Alexion Pharmaceuticals, Inc.
$104
ABBVIE INC.
$99
Shire North American Group Inc
$95
GENZYME CORPORATION
$90
Abbott Laboratories
$80
Tolmar, Inc.
$65
Tandem Diabetes Care, Inc.
$64
Clarus Therapeutics Inc.
$61
Astellas Pharma US Inc
$61
Ultragenyx Pharmaceutical Inc.
$58
Amphastar Pharmaceuticals, Inc.
$54
Ascendis Pharma Inc
$49
Chiesi USA, Inc.
$45
Supernus Pharmaceuticals, Inc.
$43
Merck Sharp & Dohme LLC
$42
Horizon Therapeutics plc
$39
Kyowa Kirin, Inc.
$37
Esperion Therapeutics, Inc.
$34
Ascensia Diabetes Care Us Inc.
$32
BETA BIONICS, INC.
$20
Insulet Corporation
$20
Vifor Pharma, Inc.
$19
Verity Pharmaceuticals Inc.
$19
DEXCOM, INC.
$18
Averitas Pharma Inc.
$17
SANOFI US SERVICES INC.
$16
OPKO Pharmaceuticals, LLC
$16
Amneal Pharmaceuticals LLC
$16
GRT US Holding, Inc.
$15
Zealand Pharma US, Inc.
$15
Endo Pharmaceuticals Inc.
$15
Amryt Pharma Holdings Ltd
$14
Top 3 companies account for 47.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · CREON · CYCLOSET · Creon · Crysvita · Cryvista · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LANTUS · LEQVIO · LYUMJEV · Levemir · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 630G · Minimed 670G System · Minimed 770G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · Omnipod · Ozempic · Pogo Automatic Blood Glucose Monitoring System · Prolia · QUTENZA · Qutenza · RECORLEV · RYBELSUS · Rayaldee · Repatha · Rybelsus · SKYTROFA · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Strensiq · TEPEZZA · TLANDO · TOUJEO · TRULICITY · TZIELD · Tlando · Tresiba · Tymlos · UBRELVY · UNITHROID · Vascepa · Veltassa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Philadelphia?
Compare endocrinologists in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
207
Per 100K population
13.1
County median income
$60,698
Nearest hospital
NAZARETH HOSPITAL
2.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Prater is a clinical cardiology specialist, with above-average Medicare volume (top 29% in PA), with low-engagement industry engagement in the top 15% of PA peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Prater experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Prater performed 543 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Prater receive payments from pharmaceutical companies?
Yes. Dr. Prater received a total of $21,224 from 61 companies across 817 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Prater's costs compare to other endocrinologists in Philadelphia?
Dr. Prater's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Prater) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →